WallStreetZenWallStreetZen

NASDAQ: VYGR
Voyager Therapeutics Inc Stock Ownership - Who owns Voyager Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Voyager Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Toby FergusonChief Medical Officer2025-04-0210,086$3.43
$34.59kSell
Alfred SandrockPresident and CEO2025-04-0210,885$3.43
$37.34kSell
Alfred SandrockPresident and CEO2025-02-2011,702$4.24
$49.62kSell
Robin SwartzCOO CBO2025-02-203,894$4.25
$16.55kSell
Todd Alfred CarterChief Scientific Officer2025-02-203,305$4.26
$14.08kSell
Alfred SandrockPresident CEO2025-02-1116,644$4.45
$74.07kSell
Todd Alfred CarterChief Scientific Officer2025-02-115,413$4.45
$24.09kSell
Sandell Jacquelyn FaheyChief Legal Officer2025-02-114,358$4.45
$19.39kSell
Robin SwartzCOO CBO2025-02-116,950$4.45
$30.93kSell
Robin SwartzCOO CBO2025-01-143,087$5.09
$15.71kSell

1 of 2

VYGR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VYGR insiders and whales buy or sell their stock.

VYGR Shareholders

What type of owners hold Voyager Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Neurocrine Biosciences Inc15.53%8,575,316$27.10MInsider
Ecor1 Capital LLC14.72%8,128,014$25.68MInsider
Mark J. Levin11.64%6,427,874$20.31MInsider
Armistice Capital LLC9.77%5,396,000$17.05MInstitution
Blackrock Inc9.70%5,356,789$16.93MInstitution
Ecor1 Capital LLC7.10%3,917,546$12.38MInstitution
Vanguard Group Inc5.82%3,215,441$10.16MInstitution
Farallon Capital Management LLC4.66%2,570,700$8.12MInstitution
Sanofi4.49%2,477,941$7.83MInsider
Dimensional Fund Advisors LP2.50%1,380,615$4.36MInstitution

1 of 3

VYGR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VYGR53.96%46.04%Net SellingNet Selling
CDXS46.56%53.44%Net BuyingNet Buying
GNFT0.41%0.00%
NGNE47.44%52.56%Net BuyingNet Selling
FULC60.93%39.07%Net Buying
View Top Biotech Stocks

Voyager Therapeutics Stock Ownership FAQ

Who owns Voyager Therapeutics?

Voyager Therapeutics (NASDAQ: VYGR) is owned by 62.50% institutional shareholders, 53.34% Voyager Therapeutics insiders, and 0.00% retail investors. Neurocrine Biosciences Inc is the largest individual Voyager Therapeutics shareholder, owning 8.58M shares representing 15.53% of the company. Neurocrine Biosciences Inc's Voyager Therapeutics shares are currently valued at $27.10M.

If you're new to stock investing, here's how to buy Voyager Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.